Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	12.14	117.28	104.58
Graham Fair Price	6.54	23.74	22.29
PEG	52.60	4.42	-2.89
Price/Book	6.96	61.62	57.61
Price/Cash Flow	254.58	349.25	98.50
Prices/Earnings	3.64	37.06	35.76
Price/Sales	15.27	70.28	60.97
Price/FCF	254.58	349.25	98.50
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	26.00	0.97	0.77
Operating Margin	2.57	0.58	0.56
ROA	7.49	0.07	0.07
ROE	0.40	0.42	3.21
ROIC	0.14	0.14	-0.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-55.11
Dividends QOQ	< 0.005	0.16	7273.81
EBIT QOQ	-0.04	< 0.005	87.90
EPS QOQ	-0.12	0.08	-32.09
FCF QOQ	0.30	-0.68	131.86
Revenue QOQ	< 0.005	-0.03	1210.32
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	108.67	0.00	inf
Days Sales Outstanding (DSO)	55.80	85.52	53.26
Inventory Turnover	0.83	0.00	inf
Debt/Capitalization	0.69	0.68	-1.47
Quick Ratio	0.81	0.81	-0.51
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.40	7.76	4.87
Cash	9.81	8.21	-16.32
Capex	-0.08	-0.41	-392.49
Free Cash Flow	4.33	1.37	-68.37
Revenue	7.00	6.81	-2.70
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.17	1.09	-6.52
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.83	2.15	17.77
Naive Interpretation	Member

06 - Financial Health · Bad

Rating